Back to search

Article

<i>In vitro</i> evolution of Remdesivir resistance reveals genome plasticity of SARS-CoV-2

2021-02-10

Abstract excerpt

Remdesivir (RDV) is used widely for COVID-19 patients despite varying results in recent clinical trials. Here, we show how serially passaging SARS-CoV-2 in vitro in the presence of RDV selected for drug-resistant viral populations. We determined that the E802D mutation in the RNA-dependent RNA polymerase was sufficient to confer decreased RDV sensitivity without affecting viral fitness. Analysis of more than 200,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6d719dd5-6e17-53de-9435-978b9f5ce7b8
DOI
10.1101/2021.02.01.429199
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>In vitro</i> evolution of Remdesivir resistance reveals genome plasticity of SARS-CoV-2DOI 10.1101/2021.02.01.429199
Select a neighboring publication to make it the new centre.